583845-15-2

Basic information

• Product Name: Hydrazinecarboxylic acid, 2-[[4-[(acetylamino)methyl]phenyl]methyl]-, 1,1-dimethylethyl ester
• CAS NO: 583845-15-2
• Molecular Formula: C15H23N3O3
• Molecular Weight: 293.366
• Mol File: 583845-15-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Hydrazinecarboxylic acid, 2-[[4-[(acetylamino)methyl]phenyl]methyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Hydrazinecarboxylic acid, 2-[[4-[(acetylamino)methyl]phenyl]methyl]-, 1,1-dimethylethyl ester(583845-15-2)
• EPA Substance Registry System: Hydrazinecarboxylic acid, 2-[[4-[(acetylamino)methyl]phenyl]methyl]-, 1,1-dimethylethyl ester(583845-15-2)

Safety Data

• Hazardous Substances Data: 583845-15-2(Hazardous Substances Data)

Upstream product

• 497164-30-4 tert-butyl N'-{1-[4-(acetylamino-methyl)phenyl]-meth-(E)-ylidene}-1-hydrazine carboxylate 
• 738615-92-4 N-(4-(1,3-dioxolan-2-yl)benzyl)acetamide 
• 156866-50-1 N-[(4-formylphenyl)methyl]acetamide 
• 104566-44-1 4-(1,3-dioxacyclopent-2-yl)benzylamine 
• 105-07-7 4-cyanobenzaldehyde 
• 66739-89-7 4-(1,3-dioxolan-2-yl)benzonitrile 

Downstream Products

• 738615-54-8 tert-butyl 2-{4-[(acetylamino)methyl]benzyl}-2-[(4-methyl-1-piperidinyl)carbonyl]-1-hydrazinecarboxylate 
• 738615-58-2 tert-butyl 2-{4-[(acetylamino)methyl]benzyl}-2-(4-morpholinylcarbonyl)-1-hydrazinecarboxylate 
• 845725-39-5 1-{4-[(acetylamino)methyl]benzyl}-N-cycloheptyl-2-(2-naphthylsulfonyl)-1-hydrazinecarboxamide 
• 845725-37-3 N-(4-{[1-(azepanylcarbonyl)-2-(2-naphthylsulfonyl)hydrazino]methyl}benzyl)acetamide 
• 845725-35-1 N-(4-{[1-[(2-methyl-1-piperidinyl)carbonyl]-2-(2-naphthylsulfonyl)hydrazino]methyl}benzyl)acetamide 
• 845725-36-2 N-(4-{[2-(2-naphthylsulfonyl)-1-(1-piperidinylcarbonyl)hydrazino]methyl}benzyl)acetamide 
• 738615-56-0 N-(4-{[1-[(4-methyl-1-piperidinyl)carbonyl]-2-(2-naphthylsulfonyl)hydrazino]methyl}benzyl)acetamide 

Relevant articles and documents

Novel non-covalent azaphenylalanine thrombin inhibitors with an aminomethyl or amino group at the P1 position

Design, synthesis and biological evaluation of a series of novel non-covalent azaphenylalanine thrombin inhibitors are presented. Replacement of the basic benzamidine moiety in azaphenylalanine derivatives by benzylamine (P1 part of a molecule) and the in